Your browser doesn't support javascript.
loading
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma.
Zinzani, Pier Luigi; Mayer, Jirí; Flowers, Christopher R; Bijou, Fontanet; De Oliveira, Ana C; Song, Yuqin; Zhang, Qingyuan; Merli, Michele; Bouabdallah, Krimo; Ganly, Peter; Zhang, Huilai; Johnson, Roderick; Martín García-Sancho, Alejandro; Provencio Pulla, Mariano; Trnený, Marek; Yuen, Sam; Tilly, Herve; Kingsley, Edwin; Tumyan, Gayane; Assouline, Sarit E; Auer, Rebecca; Ivanova, Elena; Kim, Pil; Huang, Sha; Delarue, Richard; Trotman, Judith.
Afiliación
  • Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia "Seràgnoli" and Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.
  • Mayer J; Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital, Brno, Czech Republic.
  • Flowers CR; Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX.
  • Bijou F; Institut Bergonié, Bordeaux, France.
  • De Oliveira AC; Institut Catala d'Oncologia (ICO) Hospital Duran I Reynals, Hospital, Barcelana, Spain.
  • Song Y; Peking University Cancer Hospital and Institute, Beijing, China.
  • Zhang Q; Harbin Medical University Cancer Hospital, Harbin, China.
  • Merli M; Hematology, University Hospital "Ospedale di Circolo e Fondazione Macchi"-ASST Sette Laghi, University of Insubria, Varese, Italy.
  • Bouabdallah K; Hôpital Haut-Lévêque, CHU Bordeaux, Pessac, France.
  • Ganly P; Department of Haematology, Christchurch Hospital, Christchurch, New Zealand.
  • Zhang H; Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
  • Johnson R; The Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds, United Kingdom.
  • Martín García-Sancho A; Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.
  • Provencio Pulla M; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Trnený M; Vseobecna fakultní nemocnice v Praze, Nové Mesto, Czech Republic.
  • Yuen S; Calvary Mater Newcastle, Waratah, NSW, Australia.
  • Tilly H; Henri-Becquerel Center, Rouen, France.
  • Kingsley E; Comprehensive Cancer Centers of Nevada, Las Vegas, NV.
  • Tumyan G; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.
  • Assouline SE; Jewish General Hospital, McGill, University, Montreal, Canada.
  • Auer R; St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Ivanova E; BeiGene Switzerland GmbH, Basel, Switzerland.
  • Kim P; BeiGene USA, Inc, San Mateo, CA.
  • Huang S; BeiGene (Shanghai) Co, Ltd, Shanghai, China.
  • Delarue R; BeiGene Switzerland GmbH, Basel, Switzerland.
  • Trotman J; Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia.
J Clin Oncol ; 41(33): 5107-5117, 2023 Nov 20.
Article en En | MEDLINE | ID: mdl-37506346
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Pirazoles / Pirimidinas / Linfoma Folicular Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Pirazoles / Pirimidinas / Linfoma Folicular Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos